The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

There is an increasing interest in the intestinal microbiota as a critical regulator of the development and function of the immune, nervous, and endocrine systems. Experimental work in animal models has provided the foundation for clinical studies to investigate associations between microbiota compo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohl, Hannah M., Castillo, Andrea R., Ochoa-Repáraz, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563507/
https://www.ncbi.nlm.nih.gov/pubmed/32872621
http://dx.doi.org/10.3390/diseases8030033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563507/
https://www.ncbi.nlm.nih.gov/pubmed/32872621
http://dx.doi.org/10.3390/diseases8030033

Ejemplares similares